{"date":"2026-04-03","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-04-03-1606-1mlncgv","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-04-03","time":"16:06:03","subject":"公告本公司Nintedanib Capsules 100 mg及150 mg學名藥獲得美國FDA核可並取得學名藥藥證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-04-03 16:06，「公告本公司Nintedanib Capsules 100 mg及150 mg學名藥獲得美國FDA核可並取得學名藥藥證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}